Abstract
Despite the important role of written language in everyday life, abnormalities in functional written communication have been sparsely investigated in Primary Progressive Aphasia (PPA). Prior studies have analyzed written language separately in the three variants of PPA – nonfluent (nfvPPA), logopenic (lvPPA), and semantic (svPPA) – but have rarely compared them to each other or to spoken language. Manual analysis of written language can be a time-consuming process. We developed a program which uses a language parser and quantifies content units (CU) and total units (U) in written language samples. The program was used to analyze written and spoken descriptions of the WAB Picnic scene, based on a pre-defined CU corpus. We then calculated the ratio of CU to U (CU/U Ratio) as a measure of content density. Our cohort included 115 participants (20 control participants for written, 20 control participants for spoken, 28 participants with nfvPPA, 30 with lvPPA, and 17 with svPPA). We compared written language between patients with PPA and control participants and written to spoken language in patients with the three variants of PPA. Finally, we analyzed CU and U in relation to the Progressive Aphasia Severity Scale Sum of Boxes and the Clinical Dementia Rating Sum of Boxes. Our program identified CU with a validity of 99.7% (95%CI 99.5 to 99.8) compared to manual annotation of the samples. All patients with PPA wrote fewer total units than controls (p<0.001). Patients with lvPPA (p=0.013) and svPPA (0.004) wrote fewer CU than controls. The CU/U Ratio was higher in nfvPPA and svPPA than controls (p=0.019 in both cases), but no different between lvPPA patients and controls (p=0.962). Participants with lvPPA (p<0.001) and svPPA (p=0.04) produced fewer CU in written samples compared to spoken. A two-way ANOVA showed all groups produced fewer units in written samples compared to spoken (p<0.001). However, the decrease in written CU compared to spoken was smaller than the decrease in written units compared to spoken in participants with PPA, resulting in a larger written CU/U Ratio when compared to spoken language (p<0.001). nfvPPA patients produced correlated written and spoken CU (R=0.5, p=0.009) and total units (R=0.64, p<0.001), but this was not the case for lvPPA or svPPA. Considering all PPA patients, fewer CU were produced in those with greater aphasia severity (PASS SoB, R=-0.24, p=0.04) and dementia severity (CDR SoB, R=-0.34, p=0.004). In conclusion, we observed reduced written content in patients with PPA compared to controls, with a preference for content over non-content units in patients with nfvPPA and svPPA. When comparing written to spoken language, we observed a similar “telegraphic” style in both modalities in patients with nfvPPA, which was different from patients with svPPA and lvPPA, who use significantly less non-content units in writing than in speech. Lastly, we show how our program provides a time-efficient tool, which could enable feedback and tracking of writing as an important feature of language and cognition.
Competing Interest Statement
BCD is a consultant for Acadia, Alector, Arkuda, Biogen, Denali, Eisai, Genentech, Lilly, Merck, Takeda, Wave Lifesciences and receives publishing royalties from Cambridge University Press, Elsevier, Oxford University Press.
Funding Statement
S.J.H. performed this work as a behavioral neurology/neuropsychiatry fellow on the Sydney R. Baer Jr. Track of the MGH Behavioral Neurology & Neuropsychiatry Fellowship Program, which is funded by the Sidney R. Baer Jr. Foundation. Additional support for this work was provided by funding from NIH grants R01 DC014296, R21 AG073744, R21 DC019567, and Tommy Rickles Endowed Chair in PPA Research.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics committee/IRB of Massachusetts General Hospital gave ethical approval for this work. All participants (and their care partners for patients with PPA) gave written informed consent in accordance with guidelines established by the Mass General Brigham Healthcare System Institutional Review Boards which govern human subjects research at Massachusetts General Hospital.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The code for the program described in this manuscript will be available in a public repository. The data that support the findings of this study are available on request from the corresponding author. The data are not publicly available due to the presence of information that could compromise the privacy of research participants. Derived data supporting the findings of this study are available from the corresponding author on request.
Abbreviations
- CDR SoB
- Clinical Dementia Rating Sum of Boxes
- CI
- confidence interval
- CU
- content unit(s)
- CU/U Ratio
- Content Unit/Unit Ratio
- lvPPA
- logopenic variant primary progressive aphasia
- MCI
- mild cognitive impairment
- MGH
- Massachusetts General Hospital
- nfvPPA
- non-fluent/agrammatic variant primary progressive aphasia
- PASS SoB
- Progressive Aphasia Severity Scale Sum of Boxes
- PPA
- primary progressive aphasia
- PPAOS
- primary progressive apraxia of speech
- PSP
- progressive supranuclear palsy
- svPPA
- semantic variant Primary Progressive Aphasia
- U
- Unit
- WAB-R
- Western Aphasia Battery – Revised